Researchers at the University of Alabama at Birmingham will study individuals with genetic mutations associated with Parkinson’s disease as one of 32 clinical sites of the Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson’s Research.
PPMI will enroll participants with a known mutation of the LRRK or SNCA [alpha-synuclein] gene. Previous research has shown these mutations are associated with Parkinson’s disease and account for a greater number of PD cases among certain ethnic populations and families, notably the LRRK2 mutation in those of Ashkenazi (Eastern European) Jewish, Basque and North African Berber descent. The insight investigators glean from these research volunteers will fortify current efforts to develop a disease-modifying therapy, something that currently eludes the field.
“Studying individuals with genetic mutations associated with Parkinson’s can accelerate our research toward a PD biomarker and more effective treatments,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology and primary investigator at UAB. “Although known genetic mutations account for only five to 10 percent of all Parkinson’s cases, this population can provide invaluable information about the intricacies of the disease for all patients.”
PPMI is studying clinical and imaging data and biological samples of people with a genetic mutation to identify biomarkers and speed clinical trials. PPMI will enroll 250 people with the LRRK2 mutation and Parkinson’s, and 250 people with the mutation but without Parkinson’s. Since the SNCA mutation is more rare, the study is recruiting 50 people with Parkinson’s and the mutation, and 50 people with the SNCA mutation but without PD. These participants will be followed for five years.
Interested individuals can visit www.michaeljfox.org/ppmi/genetics, call 877-836-8108 or e-mail firstname.lastname@example.org. PPMI is particularly interested in testing individuals of Ashkenazi (Eastern European) Jewish descent or their relatives with Parkinson’s. The LRRK2 mutation also accounts for more PD cases in people of North African Arab Berber or Basque descent. Study sites will recruit people with the rarer SNCA mutation through familial connections.
Biomarkers — such as cholesterol level for heart disease — are substances, processes or characteristics of the body that communicate disease risk, onset and/or progression. They aid in diagnosis and disease management and help researchers stratify for clinical trials and test new drugs more quickly by measuring biological changes rather than waiting for clinical improvement. There are no validated biomarkers for Parkinson’s disease, a reality researchers are hoping to change with PPMI.
Launched in 2010, PPMI is a longitudinal clinical study that collects standardized clinical, imaging and biologic data. Now taking place at 32 clinical sites around the world, the study completed initial enrollment of 423 recently diagnosed Parkinson’s patients and 196 controls in April 2013. That month, PPMI began recruiting individuals with the known Parkinson’s risk factors of smell loss and REM sleep behavior disorder.
“In the fourth year of PPMI, it is evident that a large-scale biomarker study is not only possible in Parkinson’s disease, but is already yielding scientific insights that could help transform the field of Parkinson’s research,” said Todd Sherer, Ph.D., CEO of The Michael J. Fox Foundation. “The exceptional investigators at sites around the world, such as at UAB, have created the infrastructure that allows us to make such strides, by working together.”
UAB Hospital first in Alabama to offer first-of-its-kind dissolving heart stentUAB Medicine is the first in Alabama to advance cardiology services by offering a first-of-its-kind heart stent that gradually dissolves in the body.posted yesterday 656 viewsPrecision medicine clinical trial available for cancer patients at UABUAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.posted 2 days ago 561 viewsTechnology improves clinical trial management and patient experienceUAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.posted 3 days ago 490 viewsNIH awards UAB three maternal and infant health grantsUAB continues to improve maternal and infant health as the only university to be a member of all three NIH perinatal networks.posted 4 days ago 752 viewsChronic fatigue syndrome flare-ups caused by straining muscles and nervesMild to moderate muscle and nerve strain provokes symptom flares in individuals with chronic fatigue syndrome.posted 5 days ago 4333 viewsUAB researchers awarded $11.5 million to study asymptomatic congenital CMV and neonatal HSVThe NIH recently awarded UAB $11.5 million to support studies that will assess treatment of babies born with congenital cytomegalovirus but no symptoms, and frequency of neonatal herpes infections in the United States and Peru.posted 9 days ago 4164 viewsPregnant women more likely to have gingivitis in first and second trimesters, study showsA new study from the UAB School of Dentistry shows that women who are pregnant are more likely to have gingivitis in their first and second trimesters, which can negatively affect mother and baby.posted 10 days ago 1126 viewsPaintFest America, a community art project, comes to UAB on July 14PaintFest America, a nationwide tour engaging cancer communities in the healing power of art, visits UAB on July 14.
BCRFA announces funding opportunity for collaborative breast cancer researchBCRFA is accepting proposals for a two-year collaborative breast cancer research award among the UAB Cancer Center, Southern Research and HudsonAlpha.posted 17 days ago 1067 viewsBaptist Health opens new multispecialty clinic with UAB Medicine at Baptist SouthClinic opens Aug. 1 and will initially offer urology, gastroenterology, endocrinology and rheumatology care.posted 18 days ago 1541 viewsUAB Metabolic and Bariatric Surgery program achieves national accreditationThe Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program says UAB meets all criteria as a Comprehensive Center to deliver safe, high-quality bariatric patient care.posted 17 days ago 1232 viewsThe warning signs of mental illness and addictionA UAB psychologist discusses addiction and recognizing the symptoms of mental illness in adults and children.posted 23 days ago 1466 viewsCoaching program will help family caregivers of cancer patients be healthyNicholas Dionne-Odom, Ph.D., will use a five-year, $935,000 award to research and develop a health-coaching program to support family caregivers for persons with advanced cancer and help them stay healthy and functioning at a high level.posted 23 days ago 1283 viewsLikelihood of widespread Zika outbreak in United States lowHigh mosquito and human population densities, combined with mosquito breeding conditions, are the central cause for Zika virus.posted 24 days ago 2313 viewsBail receives American Cancer Society awardThe grant will provide Bail a total of $30,000 of support over two years as she enters the dissertation phase of her studies.posted 24 days ago 582 viewsAvoiding and treating for contact with poisonous plantsWith these tips from UAB Emergency Medicine, know how to identify poison ivy, oak and sumac, protect yourself against allergic reaction, and treat exposed areas.posted 25 days ago 1554 viewsProton International and UAB to develop state’s first proton treatment centerThe partnership will bring a highly effective and precise alternative to traditional radiation therapy for treating cancer and some noncancerous tumors, without many of the side effects that often accompany treatment.posted 26 days ago 2578 viewsEducational forum for myelodysplastic syndromes patients and families set for June 25A workshop is set to provide information and resources for MDS patients and families June 25.posted a while back 1224 viewsIn-hospital mobility program proves successful for patients’ posthospital functionA UAB study in the Journal of the American Medical Association shows patients’ mobility while hospitalized helps maintain daily activity in older adults.posted a while back 2937 viewsIn human clinical trial, UAB to test diet’s effect on ovarian cancer patientsMetabolism-based therapies such as the ketogenic diet have the potential to become a valuable adjunct to standard cancer treatment.posted a while back 3824 views
- Event Date July 14